For både HBeAg- positive og negative patienter var HBV DNA resultaterne i uge 24 en prædiktor for et farvorabelt langtidsresultat.
For both HBeAg positive and negative patients, week 24 HBV DNA results were a predictor of long- term favourable outcomes.